INCYTE CORPORATION Cash and Restricted Cash
INCYTE CORPORATION (INCY) had Cash and Restricted Cash of $3.46 billion as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-04-28
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.46B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.10B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.46B.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.96B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-03-31 | $3.46B 10-Q · filed 2026-04-28 |
| 2025-12-31 | $3.10B 10-Q · filed 2026-04-28 |
| 2025-09-30 | $2.46B 10-Q · filed 2025-10-28 |
| 2025-06-30 | $1.96B 10-Q · filed 2025-07-29 |
| 2025-03-31 | $1.94B 10-Q · filed 2026-04-28 |
| 2024-12-31 | $1.69B 10-Q · filed 2026-04-28 |
| 2024-09-30 | $1.31B 10-Q · filed 2025-10-28 |
| 2024-06-30 | $988.92M 10-Q · filed 2025-07-29 |
| 2024-03-31 | $3.35B 10-Q · filed 2025-04-29 |
| 2023-12-31 | $3.22B 10-K · filed 2026-02-10 |
| 2023-09-30 | $3.23B 10-Q · filed 2024-10-29 |
| 2023-06-30 | $3.13B 10-Q · filed 2024-07-30 |
| 2023-03-31 | $2.82B 10-Q · filed 2024-04-30 |
| 2022-12-31 | $2.95B 10-K · filed 2026-02-10 |
| 2022-09-30 | $2.69B 10-Q · filed 2023-10-31 |
| 2022-06-30 | $2.44B 10-Q · filed 2023-08-01 |
| 2022-03-31 | $2.26B 10-Q · filed 2023-05-02 |
| 2021-12-31 | $2.06B 10-K · filed 2025-02-10 |
| 2021-09-30 | $2.00B 10-Q · filed 2022-11-01 |
| 2021-06-30 | $1.80B 10-Q · filed 2022-08-02 |
| 2021-03-31 | $1.67B 10-Q · filed 2022-05-03 |
| 2020-12-31 | $1.51B 10-K · filed 2024-02-13 |
| 2020-09-30 | $1.50B 10-Q · filed 2021-11-02 |
| 2020-06-30 | $1.33B 10-Q · filed 2021-08-03 |
| 2020-03-31 | $1.05B 10-Q · filed 2021-05-04 |
| 2019-12-31 | $1.83B 10-K · filed 2023-02-07 |
| 2019-09-30 | $1.70B 10-Q · filed 2020-11-05 |
| 2019-06-30 | $1.42B 10-Q · filed 2020-08-04 |
| 2019-03-31 | $1.30B 10-Q · filed 2020-05-05 |
| 2018-12-31 | $1.16B 10-K · filed 2022-02-08 |
| 2018-09-30 | $1.11B 10-Q · filed 2019-10-29 |
| 2018-06-30 | $929.52M 10-Q · filed 2019-07-30 |
| 2018-03-31 | $895.37M 10-Q · filed 2019-04-30 |
| 2017-12-31 | $900.43M 10-K · filed 2021-02-09 |
| 2017-09-30 | $1.13B 10-Q · filed 2018-10-30 |
| 2017-06-30 | $452.70M 10-Q · filed 2018-07-31 |
| 2017-03-31 | $362.73M 10-Q · filed 2018-05-01 |
| 2016-12-31 | $653.23M 10-K · filed 2020-02-13 |
| 2015-12-31 | $536.35M 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |